Quarterly Contract with Customer, Liability, Noncurrent in USD from Q1 2021 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary: Elite Pharmaceuticals Inc /Nv/ quarterly Contract with Customer, Liability, Noncurrent history and growth rate from Q1 2021 to Q2 2024.
Elite Pharmaceuticals Inc /Nv/ Contract with Customer, Liability, Noncurrent for the quarter ending June 30, 2024 was $2.22K, a 85.7% decline year-over-year.

Contract with Customer, Liability, Noncurrent, Quarterly (USD)

Contract with Customer, Liability, Noncurrent, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$2.22K	-$13.3K	-85.7%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$5.56K	-$13.3K	-70.6%	Mar 31, 2024	10-Q	2024-11-14
Q4 2023	$8.89K	-$13.3K	-60%	Dec 31, 2023	10-Q	2024-02-14
Q3 2023	$12.2K	-$13.3K	-52.2%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$15.6K	-$13.3K	-46.2%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$18.9K	-$13.3K	-41.4%	Mar 31, 2023	10-K	2024-07-01
Q4 2022	$22.2K	-$13.3K	-37.5%	Dec 31, 2022	10-Q	2023-02-14
Q3 2022	$25.6K			Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$28.9K			Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$32.2K	-$13.3K	-29.3%	Mar 31, 2022	10-K	2023-06-29
Q4 2021	$35.6K			Dec 31, 2021	10-Q	2022-02-14
Q1 2021	$45.6K			Mar 31, 2021	10-K	2022-06-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.